Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle
David W. Hammers(University of Florida), H. Lee Sweeney(University of Pennsylvania)
Cited by 50
Related Papers
Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse
|PLoS ONE|2012|197
How myosin VI coordinates its heads during processive movement
|The EMBO Journal|2007|73
Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice
|PLoS ONE|2010|63